Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →You can order prescription weight loss pills online through a licensed telehealth provider, but not safely without a clinician review. FDA-approved oral options include orlistat, phentermine-topiramate, naltrexone-bupropion, and short-term phentermine; oral GLP-1 weight-loss pills remain more limited than injections in current FDA labeling [3][4][5][6][7].
Can you actually order weight loss pills online?
Yes, but prescription weight loss pills should only be ordered after a licensed clinician evaluates you. The key safety step is the medical review, not the website checkout; legitimate care includes BMI, health history, medication interactions, and contraindication screening [7][8].
You do not always need an in-person visit. Many telehealth programs can evaluate patients online, prescribe when appropriate, and send the prescription to a licensed pharmacy. That is different from websites that sell “diet pills” with no prescription or no clinician review, which FDA warns may be unsafe [9].
Which weight loss pills are FDA-approved?
Several FDA-approved oral weight-loss medications exist, but each works differently and has different risks. In current FDA labeling, oral options include orlistat, phentermine-topiramate, naltrexone-bupropion, and short-term phentermine; injectable GLP-1 medicines are a separate category [1][2][3][4][5][6].
| Medication | FDA status for weight loss | How it works | Key safety considerations |
|---|---|---|---|
| Phentermine (Adipex-P) | FDA-approved for short-term weight management as an adjunct to diet and exercise [6] | Sympathomimetic appetite suppressant [6] | Can raise heart rate or blood pressure; contraindicated with cardiovascular disease, hyperthyroidism, glaucoma, agitated states, and recent MAOI use [6] |
| Phentermine-topiramate ER (Qsymia) | FDA-approved for chronic weight management in adults and certain adolescents with obesity [3] | Combines appetite-suppressing effects with topiramate-related satiety effects [3] | Contraindicated in pregnancy because of fetal risk; also contraindicated with glaucoma, hyperthyroidism, and recent MAOI use [3] |
| Orlistat (Xenical, Alli) | Xenical is prescription; Alli is OTC at a lower strength for weight loss [4] | Reduces absorption of dietary fat in the gut [4] | Can cause oily stools and GI effects; may reduce absorption of fat-soluble vitamins and is contraindicated in chronic malabsorption syndrome or cholestasis [4] |
| Naltrexone-bupropion ER (Contrave) | FDA-approved for chronic weight management in adults meeting BMI criteria [5] | Acts on appetite and reward pathways in the brain [5] | Boxed warning for suicidal thoughts and behaviors; contraindicated with seizure disorder, chronic opioid use, uncontrolled hypertension, and pregnancy [5] |
| Wegovy (semaglutide, GLP-1 receptor agonist) | FDA-approved as a once-weekly injection for chronic weight management, not as an oral Wegovy pill in current cited labeling [1] | Activates GLP-1 receptors involved in appetite and glucose regulation [1] | Can cause nausea, vomiting, diarrhea, and constipation; contraindicated with personal or family history of medullary thyroid carcinoma or MEN2 [1] |
| Zepbound / Mounjaro (tirzepatide, dual GIP/GLP-1 receptor agonist) | Zepbound is FDA-approved as an injection for chronic weight management; Mounjaro is FDA-approved for type 2 diabetes [2] | Activates GIP and GLP-1 receptors [2] | Can cause GI side effects; contraindicated with personal or family history of medullary thyroid carcinoma or MEN2 [2] |
Wegovy Pill (oral semaglutide)
People often search for Wegovy Pill, meaning oral semaglutide. Current FDA labeling supports Wegovy as injectable semaglutide for chronic weight management, while oral semaglutide has FDA labeling for type 2 diabetes under a different brand, not for chronic weight management in the cited label [1].
Oral semaglutide has been studied for obesity. In the OASIS 1 trial, oral semaglutide was associated with greater weight loss than placebo, but side effects were mainly gastrointestinal and individual results varied [12]. This does not mean an oral Wegovy pill is FDA-approved for weight loss.
Foundayo (orforglipron)
Foundayo is searched as orforglipron, a non-peptide oral GLP-1 receptor agonist. Orforglipron has been investigated in clinical trials for obesity, but it is not FDA-approved for weight loss in the cited sources, and trial reports include gastrointestinal side effects such as nausea, vomiting, constipation, and diarrhea [13].
Phentermine and phentermine-topiramate (Qsymia)
Phentermine, including Adipex-P, is FDA-approved for short-term weight management, while phentermine-topiramate ER, sold as Qsymia, is FDA-approved for chronic weight management in eligible patients [3][6]. These medicines can affect heart rate, blood pressure, mood, sleep, and pregnancy safety, so screening matters [3][6].
Orlistat (Xenical, Alli)
Orlistat is an oral lipase inhibitor that reduces dietary fat absorption. Prescription Xenical and OTC Alli are FDA-regulated options, but they can cause oily stools, urgency, and reduced absorption of fat-soluble vitamins; they are not appropriate for people with chronic malabsorption syndrome or cholestasis [4].
Contrave (naltrexone-bupropion)
Contrave combines naltrexone and bupropion and is FDA-approved for chronic weight management in adults who meet BMI criteria [5]. It is not appropriate for some people, including those with seizure disorders, chronic opioid use, uncontrolled hypertension, pregnancy, or certain eating disorders [5].
What about compounded weight loss pills?
Compounded semaglutide may be prepared by a state-licensed 503A pharmacy for an individual patient when prescribed by a clinician, but compounded medications are not FDA-approved products. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed [14].
Compounded semaglutide via 503A pharmacy
A 503A pharmacy compounds medications for individual patients based on a prescription. For oral compounded semaglutide, a clinician should explain that the product is not the same as an FDA-approved brand-name drug, and FDA has warned about risks with some compounded semaglutide products, including use of salt forms that differ from the active ingredient in approved products [14].
How compounded oral GLP-1s differ from brand-name pills
A brand-name FDA-approved medicine has an FDA-reviewed label, manufacturing standards, and clinical data for its approved use. A compounded oral GLP-1 may be prepared for a specific patient, but it does not have the same FDA approval, label, or premarket review [14].
Compounded tirzepatide via a 503A pharmacy is also not an FDA-approved product. Tirzepatide itself is FDA-approved as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes, both as injections in current labeling; compounded versions require clinician review and pharmacy quality safeguards [2][14].
Are online weight loss pills as effective as injections?
Not always. Injectable GLP-1 and GIP/GLP-1 medications have strong trial data for chronic weight management, while oral options vary by drug, dose studied, and FDA status; side effects and contraindications also differ [1][2][10][11][12][13].
In the STEP 1 trial, injectable semaglutide used with lifestyle intervention led to greater average weight loss than placebo, but gastrointestinal side effects were more common and individual results varied [10]. In the SURMOUNT-1 trial, injectable tirzepatide also produced greater average weight loss than placebo, with gastrointestinal side effects reported more often than placebo [11].
Oral options can still be useful for some patients. For example, orlistat works in the gut rather than on appetite pathways, while naltrexone-bupropion and phentermine-based options act in the brain or nervous system; each has distinct risks that may make it a better or worse fit depending on your health history [3][4][5][6].
Who qualifies for prescription weight loss pills?
Many prescription weight-loss medications use BMI thresholds of 30 or higher, or 27 or higher with at least one weight-related condition, but the exact rules depend on the medication label. A clinician also checks safety issues such as pregnancy, blood pressure, heart history, seizure risk, opioid use, and drug interactions [3][4][5][6][7].
- BMI 30 or higher may meet the weight criterion for many chronic weight-management medications [3][5][7].
- BMI 27 or higher plus a weight-related condition, such as hypertension, dyslipidemia, or type 2 diabetes, may meet criteria for some medications [3][5][7].
- Pregnancy or plans for pregnancy can rule out several options, including phentermine-topiramate and naltrexone-bupropion [3][5].
- Heart disease, uncontrolled high blood pressure, glaucoma, seizure disorder, opioid use, and thyroid cancer history can affect which medications are safe [1][2][3][5][6].
What about over-the-counter diet pills sold online?
Over-the-counter diet supplements sold online are not FDA-approved for weight loss and are not evaluated for safety and effectiveness the same way prescription drugs are. FDA has warned consumers about products marketed for weight loss that may contain hidden or unsafe ingredients [9].
Alli, the lower-strength OTC version of orlistat, is different because it is an FDA-regulated drug with labeled weight-loss use [4]. Many other products sold as “fat burners,” “metabolism pills,” or “appetite suppressants” are dietary supplements, not prescription medications, and may have uncertain ingredient quality or drug interactions [9].
How much do weight loss pills cost online?
The cost of online weight loss pills depends on the medication, insurance coverage, pharmacy, lab needs, and telehealth visit fees. Generic oral medications may cost much less than brand-name GLP-1 injections, but the lowest price is not always the safest option [7][9].
| Option | Typical cost drivers | What to verify before paying |
|---|---|---|
| Generic oral prescriptions, such as phentermine or generic orlistat where available | Medication price, clinician visit, follow-up schedule, insurance coverage | FDA-approved indication, contraindications, licensed pharmacy, and clear prescription process [4][6][9] |
| Brand-name oral medications, such as Qsymia or Contrave | Brand pricing, insurance formulary rules, prior authorization, follow-up visits | Label criteria, pregnancy and safety screening, refill monitoring, and pharmacy legitimacy [3][5][9] |
| Compounded oral semaglutide | Compounding pharmacy pricing, formulation, clinician visits, shipping, quality testing practices | That it is not FDA-approved, is prescribed for an individual patient, and comes from a state-licensed 503A pharmacy [14] |
| Injectable GLP-1 or GIP/GLP-1 medicines | Brand vs compounded status, insurance coverage, supply, pharmacy, and clinical monitoring | FDA status, boxed warnings, contraindications, side effects, and whether any compounded version is appropriate [1][2][14] |
How do you get weight loss pills online through a licensed provider?
To get weight loss pills online, choose a licensed telehealth provider that uses clinician evaluation, pharmacy dispensing, and follow-up care. Chia is one option for clinician-reviewed access to compounded GLP-1 treatment through licensed 503A pharmacy partners when appropriate; other telehealth and in-person clinicians can also evaluate prescription options.
- 1Complete a health intake with height, weight, medical history, current medications, allergies, and pregnancy status.
- 2A licensed clinician reviews BMI, weight-related conditions, contraindications, and possible drug interactions [7].
- 3If medication is appropriate, the clinician discusses FDA-approved and, when relevant, compounded options, including benefits, risks, and alternatives [1][2][3][4][5][14].
- 4A prescription is sent to a licensed pharmacy; avoid websites that ship prescription drugs without a prescription or clinician review [9].
- 5Follow-up visits monitor side effects, response, blood pressure or labs when needed, and whether the plan should change [7][8].
3-min quiz
Considering prescription options?
A clinician can review your BMI, health history, medications, and goals to see which prescription weight-loss options may be appropriate.
What are red flags for an unsafe online pharmacy?
A safe online pharmacy should require a valid prescription for prescription medicines. Unsafe pharmacy websites may sell prescription weight-loss drugs without a prescription, hide their location, offer prices that look unrealistic, or claim FDA approval for products that are not FDA-approved [9].
- No prescription or clinician evaluation is required for a prescription drug [9].
- The website claims a compounded medication is “FDA-approved,” which is not accurate [14].
- The product is labeled as semaglutide or tirzepatide but the seller does not identify a licensed U.S. pharmacy [9][14].
- The site uses pressure tactics, miracle claims, or guaranteed weight-loss promises.
- There is no clear way to contact a licensed pharmacist or prescribing clinician [9].
What side effects and safety considerations should you know?
Every weight-loss medication has possible side effects and contraindications. The safest option depends on your health history, current medications, pregnancy plans, and which risks matter most for you [1][2][3][4][5][6].
- GLP-1 medicines such as semaglutide and tirzepatide can cause nausea, vomiting, diarrhea, constipation, and abdominal pain; labels include a contraindication for people with personal or family history of medullary thyroid carcinoma or MEN2 [1][2].
- Phentermine and phentermine-topiramate can affect heart rate, blood pressure, mood, sleep, and pregnancy safety; Qsymia requires pregnancy-risk precautions because of fetal risk [3][6].
- Naltrexone-bupropion can raise blood pressure and has a boxed warning related to suicidal thoughts and behaviors; it is contraindicated with seizure disorders and chronic opioid use [5].
- Orlistat commonly causes gastrointestinal effects and may reduce absorption of fat-soluble vitamins; it is contraindicated in chronic malabsorption syndrome or cholestasis [4].
- Compounded semaglutide products are not FDA-approved, and FDA has warned about dosing errors and certain compounded semaglutide formulations [14].
You should not get prescription weight loss pills without a licensed clinician evaluation. Legitimate telehealth can happen online, but a clinician still needs to review your BMI, health history, medications, and contraindications before prescribing [7][9].
Depending on your evaluation, prescription options may include phentermine, phentermine-topiramate, orlistat, or naltrexone-bupropion. Each has different FDA labeling, benefits, side effects, and contraindications [3][4][5][6].
In current cited FDA labeling, Wegovy is semaglutide as a once-weekly injection for chronic weight management, not an oral pill [1]. Oral semaglutide has been studied for obesity, but trial results are not the same as FDA approval for an oral Wegovy pill [12].
Orforglipron is an oral non-peptide GLP-1 receptor agonist that has been studied for obesity, but it is not FDA-approved for weight loss in the cited sources. Trial reports include gastrointestinal side effects, and individual results vary [13].
No. Compounded semaglutide pills or tablets are not FDA-approved products. They may be prepared by a state-licensed 503A pharmacy for an individual patient when prescribed, but FDA does not review compounded drugs for safety, effectiveness, or quality before dispensing [14].
Many labels and clinical resources use BMI 30 or higher, or BMI 27 or higher with a weight-related condition, as starting criteria. A clinician also checks safety factors such as pregnancy, blood pressure, heart history, seizure risk, opioid use, thyroid cancer history, and drug interactions [1][2][3][5][7].
Costs vary by medication, insurance coverage, telehealth fees, pharmacy pricing, and follow-up needs. Generic oral medications may be less expensive than brand-name injections, but you should verify that the prescription and pharmacy are legitimate before paying [7][9].
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health. A licensed clinician still decides whether medication is appropriate after reviewing your health information.
3-min quiz
Talk with a clinician about online options
If you are comparing prescription weight-loss pills, compounded options, and injectable GLP-1 medicines, a licensed clinician can help you understand what is appropriate and safe for your history.
References
- 1.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration, 2024.
- 2.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration, 2023.
- 3.Vivus LLC. Qsymia (phentermine and topiramate extended-release) prescribing information. U.S. Food and Drug Administration, 2022.
- 4.Hoffmann-La Roche. Xenical (orlistat) prescribing information. U.S. Food and Drug Administration, 2012.
- 5.Currax Pharmaceuticals. Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets prescribing information. U.S. Food and Drug Administration, 2021.
- 6.Teva Pharmaceuticals USA. Adipex-P (phentermine hydrochloride) prescribing information. U.S. Food and Drug Administration, 2012.
- 7.National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight and Obesity, 2024.
- 8.Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2015.
- 9.U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information, 2024.
- 10.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021.
- 11.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
- 12.Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, Rubino DM. Oral Semaglutide 50 mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. The Lancet, 2023.
- 13.Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, Ma X, Mather KJ, Haupt A, Karanikas CA. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. New England Journal of Medicine, 2023.
- 14.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, 2025.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



